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Sarcoidosis is a multisystem granulomatous disease of unknown etiology. Ocular involvement can be the initial
manifestation, occurring by itself, or it can be associated with other systemic signs of sarcoidosis. A 31 years-old
caucasian female presented a 10-day history of decreased vision and pain in OS. Biomicroscopy revealed fine keratic
precipitates, a mild reaction in the anterior chamber and in the vitreous cavity in both eyes and a small posterior
synechiae in OS. Intraocular pressure was 12 mmHg in the OD and 9 mmHg in OS. Fundoscopy disclosed mild
swollen and hyperemic optic discs and some subretinal yellowish nodules of 1/3 to 1 disc diameter, partially
delimited, located in the posterior pole and midperiphery in both eyes. The Chest X-ray disclosed the suspicion of
hilar lymphadenopathy, especially on the left-side. The positron emission tomography (PET-scan) showed increased
18 F-fluorodeoxyglucose uptake in the paratracheal and bilateral hilar lymph nodes, indicating high local cellular
metabolism. A mediastinal lymph node biopsy was performed afterwards, which depicted non-caseating granulomas
with multinucleated giant cells and absence of acid-alcohol resistant bacilli. The patient was initially treated with oral
prednisone 60 mg/day with slow tapering over the next months. A decreased papillitis and an increased size of the
choroidal granulomas was observed after a 6-month therapy (Figs. 1B and 2B). Then, a combination of methotrexate
20 mg/week and prednisone 10 mg/day was given over the following months, which led to a gradual reduction in
size and thickness of the choroidal granulomas. A weak response to steroid monotherapy was initially observed in this
patient. The introduction of a non-steroid immunosuppressant drug (methotrexate) was associated with significant
anatomic improvement in the following months. This report raises the suggestion that an early introduction of a
nonsteroidal immunosuppressive drug to systemic steroids may be beneficial for a rapid remission of the uveitis.
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Sarcoidosis is a multisystem granulomatous disease of
unknown etiology [1]. Ocular involvement can be the
initial manifestation, occurring by itself, or it can be as-
sociated with other systemic signs of sarcoidosis [2]; eyes
are affected in 25 to 50 % of patients [3, 4]. Early and ef-
fective treatment of ocular sarcoidosis is critical because
of the high risk of progression to irreversible vision loss,
especially for glaucoma and cystoid macular edema [5].* Correspondence: grasinmayer@hotmail.com
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A 31 years-old caucasian female presented a 10-day his-
tory of decreased vision and pain in the OS. Examination
showed visual acuity of 20/20 in OD and 20/25 in OS.
Biomicroscopy revealed fine keratic precipitates, a mild re-
action in the anterior chamber and in the vitreous cavity
in both eyes and a small posterior synechiae in OS. Intra-
ocular pressure was 12 mmHg in OD and 9 mmHg in OS.
Fundoscopy disclosed mild swollen and hyperemic optic
discs and some subretinal yellowish nodules of 1/3 to 1
disc diameter, partially delimited, located in the posterior
pole and midperiphery in both eyes (Figs. 1a and 2a).
Serologic tests for toxoplasmosis, syphilis and acquired
immunodeficiency syndrome were negative as well as
skin test for tuberculosis (purified protein derivative orticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
Fig. 1 OD fundus. a Initial visit: optic disc hyperemia and edema and several yellowish subretinal lesions located in the posterior pole and lower
midperiphery. b After 6-month therapy: decreased optic disc hyperemia and edema and increased choroidal granulomas. c After 18-month
therapy: decreased choroidal granulomas
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range 9,6 to 17,1 mg/L) and angiotensin-converting en-
zyme was 87.0 IU/L (laboratory normal range 35 to
90 IU/L). The Chest X-ray disclosed the suspicion of hilar
lymphadenopathy, especially on the left-side (Fig. 3).
The PET-scan showed increased 18 F-fluorodeoxyglucose
uptake in the paratracheal and bilateral hilar lymph nodes,
indicating high local cellular metabolism (Fig. 4). A medi-
astinal lymph node biopsy was performed afterwards,
which depicted non-caseating granulomas with multinu-
cleated giant cells and absence of acid-alcohol resistant
bacilli (Fig. 5).
The patient was initially treated with oral prednisone
60 mg/day with gradual reduction. Six months after the
treatment began the prednisone intake was 20 mg/day,
when there was a decrease in papillitis and an increase
in the choroidal granuloma size (Figs. 1b and 2b). At
that visit a combination of methotrexate 20 mg/week
and prednisone 60 mg/day was prescribed. During theFig. 2 OS fundus. a Initial visit: optic disc hyperemia and edema and sever
midperiphery. b After 6-month therapy: decreased optic disc hyperemia an
therapy: decreased choroidal granulomasfollowing 12 months the prednisone daily dose was de-
creased 10 mg each visit. By the 18th month of treat-
ment the intake of prednisone was 10 mg/day, leading to
a gradual reduction in the choroidal granulomas’ size
and thickness and stabilized uncorrected visual acuity of
20/20 in both eyes (Figs. 1c and 2c).
Discussion
Ocular sarcoidosis is still rarely diagnosed in Brazil. In
2004, Gouveia et al. observed a prevalence of 2.29 %
among of the causes of uveitis among all age groups in
São Paulo (SP) [6].
The clinical suspicion of sarcoidosis requires a biopsy
to confirm the diagnosis. When the disease causes only
ocular manifestations, the diagnosis is more difficult and
may be based on ophthalmologic evaluation and even-
tual findings of a systemic granulomatous inflammation,
such as abnormal serologic tests and chest imaging [7].
Intraocular biopsy is usually not performed in theseal yellowish subretinal lesions located in the posterior pole and lower
d edema and increased choroidal granulomas. c After 18-month
Fig. 3 Chest X-ray. Chest X-ray showing a suspicion of hilar
lymphadenopathy, especially on the left-side
Fig. 5 Histopathology. Histopathology of mediastinal lymph node,
stained with hematoxylin-eosin, showing non-caseating granulomatous
inflammation and multinucleated giant cells
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ual complications.
In the present case, ocular sarcoidosis was not ac-
companied by other clinical complaints. In addition,
laboratory evaluation displayed normal values of serum
lysozyme and angiotensin-converting enzyme. How-
ever, patients with active ocular sarcoidosis may be in
systemic remission already, justifying a possible decrease
in angiotensin-converting enzyme values [8]. Moreover, a
suspected chest radiography image motivated additional
workup and a definite diagnosis of sarcoidosis through
mediastinal lymph node biopsy.
A weak response to steroid monotherapy was initially
observed in this patient. The introduction of a non-
steroid immunosuppressant drug (methotrexate) was as-
sociated with significant anatomic improvement in theFig. 4 PET-Scan. PET-Scan showing increased 18 F-fluorodeoxyglucose uptfollowing months. This fact drew attention because sys-
temic steroids are the first line of therapy for sarcoidosis
and provide faster and better outcomes even before the
combination with other pharmacologic agents [9].
Conclusion
Although sarcoidosis is a well-known disease, it rarely
causes ocular abnormalities. The present case illustrates
that ocular sarcoidosis may be unaccompanied by other
clinical complaints or by elevated serum lysozyme and
angiotensin-converting enzyme. Otherwise, complemen-
tary chest imaging and mediastinal lymph node biopsy
were critical to make the diagnosis and start prompt
therapy. This report raises the suggestion that an early
introduction of a nonsteroidal immunosuppressive drug
to systemic steroids may be beneficial for a rapid remis-
sion of the uveitis. Further studies with bigger number
of cases are needed to draw a definite conclusion.ake in multiple paratracheal and bilateral hilar lymph nodes
Mayer et al. International Journal of Retina and Vitreous  (2015) 1:7 Page 4 of 4Consent
Written informed consent was obtained from the patient
for publication of this Case report and any accompany-
ing images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
Abbreviation
PET-scan: Positron emission tomography.
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